H-1B sponsorship profile: SCIEGEN PHARMACEUTICALS INC. Across U.S. Department of Labor LCA disclosures, SCIEGEN PHARMACEUTICALS INC filed 78 Labor Condition Applications covering 78 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (78 certified of 78 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on SCIEGEN PHARMACEUTICALS INC’s H-1B petitions range from $62,000 at the low end to $185,000 at the high end, with a petition-weighted average of $87,832. That range reflects the mix of occupations the company sponsors, led by Quality Control Chemist (16 petitions at $75,423 avg), followed by Quality Assurance Chemist and Equipment Engineer. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. SCIEGEN PHARMACEUTICALS INC is headquartered in Hauppauge, NY under NAICS code 325412, and places H-1B workers across 1 state, most heavily in NY. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.